Author

Teodor‐D. Brumeanu

Observed names: T BRUMEANU, T D Brumeanu, T. Brumeanu, T. D. Brumeanu, T.-D. Brumeanu, T.D. Brumeanu, TEODOR-DORU BRUMEANU, Teodor Brumeanu, Teodor D Brumeanu, Teodor D. Brumeanu, Teodor- D. Brumeanu, Teodor-D Brumeanu, Teodor-D. Brumeanu, Teodor-Doru Brumeanu, Teodor D. Brumeanu

Institution: Uniformed Services University of the Health Sciences

Observed institutions: Naval Medical Research Command, Uniformed Services University of the Health Sciences, Kyoto University, Rockefeller University, Icahn School of Medicine at Mount Sinai

ORCID: 0000-0002-1112-7643

Observed ORCID: 0000-0002-1112-7643

OpenAlex ID: A5028088897

Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope

1997 · Sofia Casares, Kayo Inaba, et al. · The Journal of Experimental Medicine · 318

Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells

2011 · Rebecca Danner, Snehal N. Chaudhari, et al. · PLoS ONE · 208

The RTS,S malaria vaccine

2010 · Sofia Casares, Teodor-Doru Brumeanu, et al. · Vaccine · 196

Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide–MHC class II chimera

2002 · Sofia Casares, Alicia Hurtado, et al. · Nature Immunology · 116

Analysis of lipid rafts in T cells

2004 · S THOMAS, A PREDAPAIS, et al. · Molecular Immunology · 78

Doxorubicin-induced cell death in highly invasive human gliomas.

1999 · A C Stan, S Casares, et al. · PubMed · 71

Increased Membrane Cholesterol in Lymphocytes Diverts T-Cells toward an Inflammatory Response

2012 · Jacqueline Surls, Cristina Nazarov-Stoica, et al. · PLoS ONE · 70

Antigen-Specific Signaling by a Soluble, Dimeric Peptide/Major Histocompatibility Complex Class II/Fc Chimera Leading to T Helper Cell Type 2 Differentiation

1999 · Sofia Casares, Cong S. Zong, et al. · The Journal of Experimental Medicine · 64

Towards development of T-cell vaccines

1998 · Constantin A. Bona, Sofia Casares, et al. · Immunology Today · 60

Differential effect of HLA class-I versus class-II transgenes on human T and B cell reconstitution and function in NRG mice

2016 · Sai Majji, Wathsala Wijayalath, et al. · Scientific Reports · 54

Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen.

1999 · A C Stan, D L Radu, et al. · PubMed · 54

Humanized HLA-DR4.RagKO.IL2RγcKO.NOD (DRAG) mice sustain the complex vertebrate life cycle of Plasmodium falciparum malaria

2014 · Wathsala Wijayalath, Sai Majji, et al. · Malaria Journal · 53

CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes

2001 · Alexandru C. Stan, Sofia Casares, et al. · European Journal of Immunology · 49

Double Negative (CD3+4−8−) TCRαβ Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

2010 · Beverly Duncan, Cristina Nazarov–Stoica, et al. · PLoS ONE · 48

Characterization of mutated protein encoded by partially duplicated fibrillin-1 gene in tight skin (TSK) mice

1999 · Shinichiro Saito, Hiroyuki Nishimura, et al. · Molecular Immunology · 44

Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus.

1993 · T D Brumeanu, W J Swiggard, et al. · The Journal of Experimental Medicine · 44

Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination

2010 · Jacqueline Surls, Cristina Nazarov-Stoica, et al. · Vaccine · 35

Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD)

2017 · Mirian Mendoza, Angela Ballesteros, et al. · Human Vaccines & Immunotherapeutics · 33

Immunochemical and molecular characterization of anti-RNA polymerase I autoantibodies produced by tight skin mouse.

1993 · S Shibata, T Muryoi, et al. · Journal of Clinical Investigation · 33

Engineering and characterization of a murine MHC class II- immunoglobulin chimera expressing an immunodominant CD4 T viral epitope

1997 · S. Casares, C. A. Bona, et al. · Protein Engineering Design and Selection · 30

CD28 Signaling in T Regulatory Precursors Requires p56lck and Rafts Integrity to Stabilize the Foxp3 Message

2009 · Cristina Nazarov-Stoica, Jacqueline Surls, et al. · The Journal of Immunology · 29

A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56 lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera

2003 · Sunil Thomas, Rajeev Kumar, et al. · The Journal of Immunology · 29

Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus

1997 · T D Brumeanu, S Casares, et al. · Journal of Virology · 29

Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes

1996 · T.-D. Brumeanu, A. Bot, et al. · Immunotechnology · 25

Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II–peptide chimera

2001 · Sofia Casares, Alexandru C. Stan, et al. · Nature Biotechnology · 24

Works count: 69

Citation count: 2,290

H-index: 24

I10-index: 51